13043SCONEOpenTransformation of Dormant Spinal Networks to Mitigate Symptoms of Neurogenic Bladder ( SCONE Clinical Study )The purpose of this study is to evaluate the effectiveness and safety of SCONE neuromodulation therapy after 12 weeks of therapy in comparison to inactive sham control in improving symptoms of Neurogenic Lower Urinary Tract DysfunctionSPNX-001NCT05301335IndustryAdultTreatmentDevice: SCONEIIGlobalOtherThis study investigates the following conditions or diseases: Neurogenic Bladder
Spinal Cord Injuries
Stroke
Multiple SclerosisGroah, SuzanneMedstar National Rehabilitation HospitalMedStar Neuroscience & Rehab Research Network2021R3.1 Build 22 <a href="https://advarra.com" target="_blank">© 2024 Advarra, Inc.</a>